Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Src-mediated morphology transition of lung cancer cells in three-dimensional organotypic culture

Nguyen, HT and Zhuang, Y and Sun, L and Kantrow, SP and Kolls, JK and You, Z and Zhuo, Y and Shan, B (2013) Src-mediated morphology transition of lung cancer cells in three-dimensional organotypic culture. Cancer Cell International, 13 (1).

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (1MB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

A fribotic tumor microenvironment promotes progression of cancer. In this study, we utilize a reconstituted basement membrane mimics Matrigel based three-dimensional organotypic culture (rBM 3-D) to investigate the mechanisms that mediate the tumor promoting effects of the fibrogenic mediators TGF-β1 and type I collagen (Col-1) on lung adenocarcinoma cells. Similar to normal alveolar epithelial cells, the well-differentiated lung adenocarcinoma cells in rBM 3-D culture undergo acinar morphogeneis that features polarized epithelial cell spheres with a single central lumen. Either TGF-β1 or Col-1 modestly distorts acinar morphogenesis. On the other hand, TGF-β1 and Col-1 synergistically induce a transition from acinar morphology into stellate morphology that is characteristic of invasive and metastatic cancer cells. Inhibition of the Src kinase activity abrogates induction of stellate morphology, activation of Akt and mTOR, and the expression of tumor promoting genes by TGF-β1 and Col-1. To a similar extent, pharmacological inhibition of mTOR abrogates the cellular responses to TGF-β1 and Col-1. In summary, we demonstrate that TGF-β1 and Col-1 promote stellate morphogenesis of lung cancer cells. Our findings further suggest that the Src-Akt-mTOR axis mediates stellate morphogenesis. These findings also indicate that rBM 3-D culture can serve as an ideal platform for swift and cost-effective screening of therapeutic candidates at the interface of the tumor and its microenvironment. © 2013 Nguyen et al.; licensee BioMed Central Ltd.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Nguyen, HT
Zhuang, Y
Sun, L
Kantrow, SP
Kolls, JKjkk23@pitt.eduJKK23
You, Z
Zhuo, Y
Shan, B
Date: 14 February 2013
Date Type: Publication
Journal or Publication Title: Cancer Cell International
Volume: 13
Number: 1
DOI or Unique Handle: 10.1186/1475-2867-13-16
Schools and Programs: School of Medicine > Pediatrics
Refereed: Yes
Date Deposited: 06 Oct 2016 14:32
Last Modified: 29 Jan 2019 15:55
URI: http://d-scholarship.pitt.edu/id/eprint/29759

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item